Evidence map›Paper›PMID 27924082›Full record

ArticleInternational journal of obesity (2005)2017

Duodenal endoluminal barrier sleeve alters gut microbiota of ZDF rats.

T Kim, C L Holleman, T Ptacek, C D Morrow, K M Habegger

Open access · greenAbstract read
In one paragraph

Article in International journal of obesity (2005), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
1.5field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 18 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

T KimComprehensive Diabetes Center and Department of Medicine-Endocrinology, Diabetes and Metabolism, University of Alabama at Birmingham, Birmingham, AL, USA.
C L HollemanComprehensive Diabetes Center and Department of Medicine-Endocrinology, Diabetes and Metabolism, University of Alabama at Birmingham, Birmingham, AL, USA.
T PtacekCenter for Clinical and Translational Sciences, University of Alabama at Birmingham, Birmingham, AL, USA.
C D MorrowDepartment of Microbiology, University of Alabama at Birmingham, Birmingham, AL, USA.
K M HabeggerComprehensive Diabetes Center and Department of Medicine-Endocrinology, Diabetes and Metabolism, University of Alabama at Birmingham, Birmingham, AL, USA.
University of Alabama at Birmingham · US

Funding

XRAY CRYSTALLOGRAPHYP30CA013148 · NCI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Robert S Welner · 1985 to 2026
$165.9M
Virology CoreP30AI027767 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Latesha Ellen Elopre · 1988 to 2026
$84.1M
UAB Center for Clinical and Translational Science (CCTS)UL1TR001417 · NCATS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI KIMBERLY, ROBERT P. · 2015 to 2018
$31.4M
UAB Center for Clinical and Translational Science (CCTS) UL1UL1TR000165 · NCATS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI KIMBERLY, ROBERT P. · 2012 to 2013
$9.6M
UAB Skin Diseases Research CenterP30AR050948 · NIAMS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI GRIZZLE, WILLIAM E. · 2004 to 2013
$5.5M
Glucagon Mediated Potentiation of Insulin Sensitivity in Glucose MetabolismR01DK112934 · NIDDK · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI HABEGGER, KIRK MICHAEL · 2017 to 2021
$1.7M
Duodenal nutrient exclusion enhances glucose metabolism via CNS regulationK01DK098319 · NIDDK · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI HABEGGER, KIRK MICHAEL · 2014 to 2016
$456k
NCATS NIH HHS UL1 TR000165NCATS NIH HHS UL1 TR001417NCI NIH HHS P30 CA013148NIAID NIH HHS P30 AI027767NIAMS NIH HHS P30 AR050948NIDDK NIH HHS K01 DK098319NIDDK NIH HHS R01 DK112934
6 · The paper itself

Abstract

BACKGROUND/

objectivesThe combination of energy dense diets and reduced energy expenditure in modern society has escalated the prevalence of obesity and obesity-related comorbidities. Among these disease states, type-2 diabetics (T2D) are disproportionately associated with obesity, suggesting a shared etiology. In conjunction with defects in hormonal and inflammatory states, obesity and T2D are also characterized by dysbiosis.

methodsWe have recently described the beneficial effects of duodenal nutrient exclusion, as induced by the duodenal endoluminal sleeve (DES); including body weight loss, prevented fat mass accumulation, and improved glucose tolerance in the ZDF rat, a rodent model of obesity and type-2 diabetes (T2D). To assess the relative role of DES on hindgut microbiota in the context of these metabolic changes, we analyzed cecal samples from rats implanted with a duodenal endoluminal sleeve (DES), or a sham control of this procedure. A group of pair-fed (pf) sham controls was also included to account for changes induced by reduced body weight and food intake.

resultsAnalysis of hindgut microbiota following DES in the ZDF rat elucidated discrete changes in several microbial populations including a reduction in Paraprevotella family members of the Clostridiales order along with an increase in Akkermansia muciniphila and species of the Allobaculum and Bifidobacterium genera.

conclusionsAltogether, these observations suggest that like Roux-en Y gastric bypass (RYGB) and Metformin, regulation of gut microbiota may be a contributing factor to the therapeutic effects of DES.

Indexed as

Gastrointestinal MicrobiomeAnimalsDiabetes Mellitus, Type 2Disease Models, AnimalDuodenumDysbiosisGastric BypassHypoglycemic AgentsMetforminObesityRatsRats, ZuckerWeight LossHypoglycemic AgentsMetformin

Identifiers

PMID27924082
PMCPMC5340580
OpenAlexW2560454894

What OpenQuestion holds

Texttitle and abstract
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.